Serum IgE and absolute eosinophil count-A valuable serological markers in childhood urticaria

---

Original Article

Author Details : Nirmal Smith A*, Poorana B, Sucindar M, S Chidambaranathan, PK Kaviarasan

Volume : 9, Issue : 1, Year : 2023

Article Page : 40-43

https://doi.org/10.18231/j.ijced.2023.006

Suggest article by email

Get Permission

---

Abstract

Background: Urticaria is the most common skin disorder in children presenting to the paediatric department. Sometimes it can also present with angioedema which is an emergency condition requiring immediate treatment. Hence this study signifies the importance of Absolute eosinophil count and serum IgE in childhood urticaria and its correlation with disease severity and management.
Objectives: To analyse the Absolute eosinophil count and serum IgE in children with urticaria from age group of 1-12 years and its correlation with disease severity.
Materials and Materials: An observational study on 49 children with urticaria and measurement of Absolute eosinophil count and serum IgE and categorised based on urticaria activity score.
Results: Most common age group affected was 5-12 years and mean age was 6.75±3.47. Out of 49 children, 97.95% of the affected children have raised serum IgE levels, 39% of the affected children have raised Absolute Eosinophil Count. There was also increase in serum IgE levels with increase in AEC levels were found.
Conclusion: The disease severity increases with increasing levels of absolute eosinophil count and serum IgE in children with urticaria. Hence this study suggests that absolute eosinophil count and serum IgE should be regareded as a valuable markers in childhood urticaria.
 

Keywords: Urticaria, Absolute eosinophil count, Serum IgE, Urticaria activity score

How to cite : Nirmal Smith A, Poorana B, Sucindar M, Chidambaranathan S, Kaviarasan P, Serum IgE and absolute eosinophil count-A valuable serological markers in childhood urticaria. IP Indian J Clin Exp Dermatol 2023;9(1):40-43

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.